Inventor

BUTTERWECK HARALD ARNO

AT14 patents

⚠️ This page may combine multiple inventors who share the name “BUTTERWECK HARALD ARNO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BAXALTA INC

5 patents

US10738107B2Aug 11, 2020

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs

BAXALTA INC4 citations82

US10125189B2Nov 13, 2018

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

BAXALTA INC7 citations82

US9556261B2Jan 31, 2017

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

BAXALTA INC3 citations71

US9896501B2Feb 20, 2018

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

BAXALTA INC1 citations60

US9855331B2Jan 2, 2018

Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH

BAXALTA INC1 citations48

TESCHNER WOLFGANG

2 patents

US8546548B2Oct 1, 2013

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

TESCHNER WOLFGANG17 citations89

US9403899B2Aug 2, 2016

Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

TESCHNER WOLFGANG0 citations37

BRUCKSCHWAIGER LEOPOLD

2 patents

US8993734B2Mar 31, 2015

Method to produce an immunoglobulin preparation with improved yield

BRUCKSCHWAIGER LEOPOLD14 citations88

US8796430B2Aug 5, 2014

Method to produce an immunoglobulin preparation with improved yield

BRUCKSCHWAIGER LEOPOLD4 citations69

BAXTER INT

2 patents

US9175068B2Nov 3, 2015

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

BAXTER INT8 citations82

US8940877B2Jan 27, 2015

Method to produce an immunoglobulin preparation with improved yield

BAXTER INT7 citations82

TAKEDA PHARMACEUTICALS CO

2 patents

US12365723B2Jul 22, 2025

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS

TAKEDA PHARMACEUTICALS CO0 citations60

US11242380B2Feb 8, 2022

Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use

TAKEDA PHARMACEUTICALS CO0 citations60

BUTTERWECK HARALD ARNO

1 patent

US8795658B2Aug 5, 2014

Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH

BUTTERWECK HARALD ARNO3 citations54